APOC2 and Insulin resistance: Cluster 3 (persistent high TyG) may suggest sustained insulin resistance and impaired ApoC-II/A-V function (19), even with substantial hypoglycemic drug use, which offsets clinical intervention effects, which may be related to drug target resistance (e.g., decreased insulin receptor sensitivity) or comorbid uncontrolled inflammatory factors.